
CEO of Lundbeckfond Ventures, Mette Kirstine Agger, encourages Danish biotech companies to gain a more commercial outlook, for example by bringing business people into the companies.
Generally speaking, she believes that many small biotech companies do not have adequate focus on the commercial positioning of their companies.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app